Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Tobiasson, Magnus  [Clear All Filters]
Journal Article
Dolinska M, Cai H, Mansson A, Shen J, Xiao P, Bouderlique T, Li X, Leonard E, Chang M, Gao Y, et al. Characterization of Bone Marrow Niche in Chronic Myeloid Leukemia Patients Identifies CXCL14 as a New Therapeutic Option. Blood. 2023.
Hofman IJuliana, Mortera-Blanco T, Moura PLuis, Vestlund J, Larsson SVenckute, Elvarsdottir EMaria, Walldin G, Tobiasson M, Sander B, Dimitriou M, et al. The extent of residual WT hematopoietic stem and progenitor cells is associated with the degree of anemia in SF3B1-mutated MDS-RS patients. Blood Adv. 2022.
Dimitriou M, Mortera-Blanco T, Tobiasson M, Mazzi S, Lehander M, Högstrand K, Karimi M, Walldin G, Jansson M, Vonlanthen S, et al. Identification and surveillance of rare relapse-initiating stem cells during complete remission post-transplantation. Blood. 2023.
Todisco G, Creignou M, Bernard E, Björklund A-C, Moura PLuis, Tesi B, Blanco TMortera, Sander B, Jansson M, Walldin G, et al. Integrated genomic and transcriptomic analysis improves disease classification and risk stratification of MDS with ring sideroblasts. Clin Cancer Res. 2023.
Tobiasson M, Pandzic T, Illman J, Nilsson L, Weström S, Ejerblad E, Olesen G, Björklund A, Kittang AOlsnes, Werlenius O, et al. Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation. J Clin Oncol. 2024:JCO2301159.